Cidara Therapeutics Inc (CDTX) Technical Analysis
$221.02▲0.06%
Market is closed - opens 8 PM, 05 Jan 2026
Insights
- Cidara Therapeutics is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Cidara Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Cidara Therapeutics stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Cidara Therapeutics stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 83.88 | Sell |
Stochastic | 94.66, 89.53 | Neutral |
Ultimate Oscillator | 68.1 | Neutral |
Stochastic Relative Strength Index | 15.43, 10.26 | Buy |
Moving Average Convergence Divergence | 9.17, 12.47 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 220.77 | Buy |
20 | 220.49 | Buy |
50 | 180.15 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 220.57 | Buy |
20 | 216.2 | Buy |
50 | 186.57 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 220.66 | Neutral |
20 | 220.42 | Neutral |
50 | 196.51 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 221.71 | Sell |
20 | 230.26 | Sell |
50 | 233.99 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 219.78 | Sell |
20 | 221.42 | Sell |
50 | 244.99 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 221.19 |
Resistance L2 | 221.08 |
Resistance L1 | 220.98 |
Pivot Point | 220.87 |
Support L1 | 220.77 |
Support L2 | 220.66 |
Support L3 | 220.56 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.